LEXINGTON, Mass. (PRWEB)
October 03, 2019

Hemanext, a privately held medical technology company dedicated to creating a world with fewer and better transfusions, today announced its significant presence at the American Association of Blood Banks (AABB) Annual Meeting, Oct. 19 – 22, 2019 in San Antonio, Texas.

Noteworthy is that AABB accepted for presentation all eight abstracts submitted by Hemanext and its research collaborators. Additional dialogue about the clinical needs surrounding improved red blood cells (RBCs) will occur at the Hemanext booth (#930) in Exhibition Halls 2-3.

“As we continue on our path toward CE Mark designation and FDA submission for our first product, HEMANEXT ONE®, we appreciate the work of our research collaborators,” said Hemanext President and CEO Martin Cannon. “The eight abstracts help paint a compelling picture of the potential for hypoxic RBCs to enhance patient care.”

Hemanext’s technology delivers an innovative approach to minimizing oxidative damage of stored blood, which continues to be a key unmet need that may significantly impact patient care. To learn more about this unmet need, Hemanext recommends attendance at the educational session entitled “RBC Storage: The Oxygen Paradox.” Chair France Pirenne, MD, PhD, Medical Director of the French Blood Establishment (EFS) of Ile de France and president of the French Society of Blood Transfusion, will lead a scientific discussion with three highly respected experts in transfusion medicine on Saturday, Oct. 19, 8:00 – 9:30am at the Convention Center’s Hemisfair Ballroom II.

Click here to learn more about the educational session.

Below are three of the eight preclinical abstracts investigating the potential benefits of hypoxic red blood cells (RBCs) that Hemanext and its collaborators will present during the annual meeting:

24h RECOVERY: Researcher Angelo D’Alessandro, PhD, Assistant Professor, University of Colorado Denver School of Medicine, Biochemistry and Molecular Genetics, will share findings from “Metabolic Predictors of 24h Post-Transfusion Recovery in End of Storage Control and Hypoxic Red Blood Cells” (Abstract OA3-ST4-29, oral presentation, Saturday, Oct. 19, 2:00 – 2:15pm at Convention Center Room 302).

RBC LESION IMPROVEMENT: Comparative analysis of hypoxic vs. conventional storage of RBCs is the focus of “Long-term hypoxic storage of red blood cells results in amelioration of lesion hallmarks and Increased in vivo recovery at 24 hours post-transfusion” (Abstract P-NE-17, poster presentation, Sunday, Oct. 20, 1:00 – 2:00pm, Convention Center Exhibit Halls 2-3).

SICKLE CELL ANEMIA: With transfusion therapy well-established as an important treatment for sickle cell anemia (SCA) and sickle cell disease (SCD), research into the appropriateness of hypoxically stored blood for this patient population is warranted. “Effects of hypoxic red blood cells on sickling kinetics of red blood cells from patients with sickle cell disease” (Abstract P-NE-5, poster presentation, Sunday, Oct. 20, 1:00 – 2:00pm, Convention Center Exhibit Halls 2-3).

Click here for information on all eight research abstracts that Hemanext will present at AABB 2019.

According to Paul M. Ness, MD, Senior Director, Division of Transfusion Medicine, Professor of Pathology, Johns Hopkins University School of Medicine, former editor of Transfusion—the Journal of the American Association of Blood Banks (AABB) and past president of AABB, “Transfusion medicine physicians and their teams are on a perpetual search for new and better ways to improve outcomes for patients requiring massive and/or chronic RBC transfusions. Preclinical data being presented at AABB 2019 appears to reinforce the potential of hypoxically stored RBCs to improve patient care. My peers and I hope that these extremely encouraging data sets are validated in future clinical trials.”

ABOUT HEMANEXT

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy. The company’s research and development efforts center on the study and future commercialization of hypoxically stored red blood cells (RBCs). HEMANEXT ONE®, our initial product offering, is designed to improve the quality of life for chronic and high-volume transfusion patients while reducing costs.

Visit Hemanext.com to learn more.

Share article on social media or email:

NASHVILLE, Tenn. (PRWEB)
October 03, 2019

The Ninth Annual Censis Technologies Users Conference (CtUC) took place on September 22nd through the 24th at the Gaylord Opryland Resort & Convention Center in Nashville, Tenn. This year, the Censis Community broke records with over 300 in attendance engaging in hands-on workshops, portfolio-specific breakout sessions, and nightly events. General sessions included keynote speaker, former U.S. Surgeon General, and the first African American woman to hold that post, Dr. M. Joycelyn Elders and Lieutenant General (Retired) Keith M. Huber.

“Year after year, CtUC continues to expand into a must-attend event for our user community,” said Censis CEO, Randy Smith. “With over one-third of first-time attendees joining us this year, we cannot only share the future of Censis’ technologies with them but learn what they need from us to better serve them for years to come.”

The Censis Technologies Users Conference (CtUC) is the largest and longest-running users’ conference in the industry, offering cutting-edge insight from top Sterile Processing and Perioperative experts across the country. Through numerous educational sessions, exciting events, valuable networking opportunities, and more, CtUC is the one event healthcare professionals can’t afford to miss. Information for the Tenth Annual Censis Technologies Users Conference in 2020 will be released within the next few months. To learn more about the conference and Censis Technologies, please visit the Censis website at http://www.censis.com.

About Censis Technologies

Censis Technologies, based in Franklin, Tennessee, is the leader in surgical instrument and asset management software. Censis offers a range of solutions, including CensiTrac, which is a highly advanced, web-based software system focused on maximizing OR throughput and regulatory compliance. Censis Technologies’ software is deployed in over 1,300 hospitals in the United States, Canada, and Australia. For more information, visit http://www.censis.com.

Share article on social media or email:

NEW YORK (PRWEB)
October 03, 2019

Mount Sinai Health System has earned the 2019 College of Healthcare Information Management Executives (CHIME) Most Wired recognition according to survey results released this month. Mount Sinai was certified level 8, one of the highest distinctions, because of the effective application of advance technologies into clinical and business programs to improve health and care in communities.

“Healthcare organizations across the globe are continually striving to raise the standard of care, pushing themselves and their peers to do better,” said CHIME President and CEO Russ Branzell. “We designed Most Wired to identify and share those leading practices so everyone can benefit. It is an honor to be among those that perform at the highest levels, knowing that the excellence they achieve will impact patients for years to come.”    

“We are honored to receive the 2019 CHIME HealthCare’s Most Wired recognition,” said Kumar Chatani, Executive Vice President, Chief Information Officer & Dean for Information Technology at Mount Sinai Health System. “Mount Sinai has made substantial investments in technology to support our mission providing compassionate patient care in the many diverse communities we serve. This includes utilizing patient-friendly mobile apps that enhance patient experiences and leveraging emerging technologies that improve patient outcomes, including predictive analytics, machine learning and artificial intelligence.”

Innovation in patient care embraces emerging technologies and underscores the need for secure patient information exchange. Most Wired hospitals are transforming care delivery with knowledge gained from data and analytics, and investing in analytics to support new delivery models and effective decision-making and training clinicians on how to use analytics to improve quality, provide access, and control costs.

A total of 16,168 organizations were represented in the 2019 Most Wired program, which this year included three separate surveys: domestic, ambulatory and international. The surveys assessed the adoption, integration and impact of technologies in healthcare organizations at all stages of development, from early development to industry leading. Each participating organization received a customized benchmarking report, an overall score and scores for individual levels in eight segments: infrastructure; security; business/disaster recovery; administrative/supply chain; analytics/data management; interoperability/population health; patient engagement; and clinical quality/safety. Participants can use the report and scores to identify strengths and opportunities for improvement.

This is the second year that CHIME has conducted the survey and overseen the program. Last year CHIME made numerous improvements to the survey, governance and scoring methodology. This year CHIME added an ambulatory survey in addition to the domestic survey, expanded international outreach and incorporated an improved system that allows participating organizations to better benchmark their level of adoption and outcomes achieved. The system includes Most Wired certification at a level that reflects an organization’s overall performance. CHIME also revised the customized benchmarking report for ease of use and will again publish a report based on Most Wired responses to identify industry trends in 2019.    

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

About CHIME

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), Chief Digital Officers (CDOs) and other senior healthcare IT leaders. With more than 2,900 members in 56 countries and over 150 healthcare IT business partners and professional services firms, CHIME provides a highly interactive, trusted environment enabling senior professional and industry leaders to collaborate; exchange best practices; address professional development needs; and advocate the effective use of information management to improve the health and care in the communities they serve. For more information, please visit https://chimecentral.org/.

Share article on social media or email:

MALVERN, Pa. (PRWEB)
October 03, 2019

HMP, a leading healthcare event and education company, today announced the launch of a new practicing clinician web portal as part of its Why Wound Care?™ (WWC) endeavor.

Created in 2015, the Why Wound Care™ initiative focuses on delivering education and increasing awareness for specialty careers in wound care and wound management. The initiative includes a dedicated website that provides a range of robust educational content and resources for faculty as well as medical and nursing students — and now, practicing clinicians — that feature free instructional courses, access to leading wound care journals, and discounts on continuing education.

“The launch of the Practicing Clinician portal further expands the scope of our work,” said Peter Norris, executive vice president, HMP. “With America’s aging population and the epidemic of diabetes and obesity, there has never been a greater need for wound clinicians in acute, sub-acute, or post-acute care settings. Research shows that too few clinicians receive sufficient training in the proper treatment and management of wounds during their academic training, and many outmoded therapeutic concepts are still in practice today. With the new portal, we’re working to address these educational gaps, increase the number of wound care specialists, and ultimately improve patient outcomes.”

An elite group of volunteers comprising multidisciplinary wound care practitioners guided the development of the new portal. Practicing professionals now have access to complimentary, evidence-based wound care materials, including:

• 
  Sixteen video modules on foundational wound care topics, including Acute Wound Healing Processes, Burns, Pressure Injuries, Venous Ulcers, Wound Infections;
• Eighteen slide modules, including Risk Factors/Comorbidities for Chronic Wound Development, Wound Dressings, Wound Assessment, Wound Cleansing and Irrigation, and Pain Assessment and Management;
• Five physical therapist-focused video modules;
• Four podiatry-focused video modules; and
• Downloadable PDFs of all 25 chapters of Chronic Wound Care: The Essentials

“We’re seeing more physical therapists looking to increase the number of wound care patients they see in their practice, especially with the advent of the new Patient Driven Payment Model (PDPM) and Patient Driven Grouping Model (PDGM) within post-acute care settings,” said Joseph McCulloch, PT, PhD, CWS, FAPTA, physical therapy chair for the initiative and former dean of the School of Allied Health Professions at Louisiana State University (LSU) Health Sciences Center. “I was pleased to be a part of expanding the Why Wound Care?™ resources to address the areas of clinical physical therapy expertise in order to optimize patient care.”

“Podiatrists who specialize in wounds are key members of any true multidisciplinary care team,” said Paul Kim, DPM, MS, podiatric surgeon, professor of plastic surgery and orthopedic surgery, medical director of the wound program at the University of Texas Southwestern, and Why Wound Care?™ board member. “I was pleased to lead the development of the podiatry section of the new portal and was honored to work with other podiatry experts who helped ensure the wound care content would be relevant not only to podiatrists, but to other practitioners new to this specialty.”

To learn more about Why Wound Care™ and to access these free resources, visit whywoundcare.com.

About HMP

HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Share article on social media or email:

NEW YORK (PRWEB)
October 04, 2019

AKTIV Against Cancer, the organization co-founded by legendary runner Grete Waitz, and Helle Aanesen, today announced that author, television host, entrepreneur and philanthropist Chip Gaines will be the recipient of the 5th Annual AKTIV Against Cancer Award, which will be presented at a ceremony on November 14th at the historic New York Athletic Club.

Chip Gaines is the co-founder of Magnolia, a Waco, Texas-based company he started with his wife Joanna in 2003. In 2018, Chip launched Magnolia’s inaugural Silo District Marathon following a chance meeting with past AKTIV Against Cancer Inspiration Award recipient Gabrielle “Gabe” Grunewald. Since then, Chip has helped raise more than $1 million for the Brave Like Gabe Foundation – it is because of these philanthropic endeavors that AKTIV Against Cancer has chosen to honor Chip Gaines as the recipient of this year’s award.

“We are thrilled to have Chip join us as this year’s recipient,” said Helle Aanesen, co-founder of AKTIV Against Cancer, “The work he and Joanna have done to support causes far and wide, and all they have done around our mission and in honor and memory of Gabe Grunewald, will certainly inspire all of us as well as everyone in our combined communities.

In addition to the award to Chip Gaines, AKTIV Against Cancer will also be honoring two supporters for their work. Cancer survivor and advocate Aubrey Barr has run over 30 marathons with Fred’s Team, including the New York City Marathon and the Boston Marathon. Additionally, longtime Fred’s Team coach Jeff Rochford has trained and coached thousands of Fred’s Team runners across finish lines. Fred’s Team, named in honor of New York City Marathon co-founder Fred Lebow, is Memorial Sloan Kettering Cancer Center’s running program, which has raised more than $85 million for cancer research since 1995.

The luncheon will be supported by adidas and the May and Samuel Rudin Family Foundation. Previous honorees of this award include Dr. Jordan Metzl & Kikkan Randall (2018), The Rudin Family & the late Gabriel Grunewald (2017), Meb Keflezighi (2016), and Mary Wittenberg (2015).

For more information about AKTIV Against Cancer or this year’s award ceremony, please visit http://www.aktivagainstcancer.org

ABOUT AKTIV AGAINST CANCER

AKTIV Against Cancer works to ensure that physical activity will become part of cancer treatment. We support cutting edge research on the benefits of exercise for the prevention and treatment of cancer, as well as the creation of fitness programs and facilities in cancer treatment centers. AKTIV Against Cancer was co-founded by 9-time NYC Marathon Champion and Norwegian running superstar Grete Waitz and current Executive Director Helle Aanesen in Norway in 2007. After among other having opened sixteen (16) physical activity centers in cancer hospitals throughout Norway, AKTIV Against Cancer established its official presence in the United States in 2014. AKTIV Against Cancer has committed to funding $3.3 million towards cutting edge exercise oncology research at Memorial Sloan Kettering Cancer Center. The foundation also contribute to building up cancer treatment in Ethiopia by educating oncologists and cancer nurses and making sure their competence will be present at all University hospitals in the country.

Share article on social media or email:

HOUSTON (PRWEB)
October 04, 2019

GREFFEX, INC. was awarded a contract of $2.8M with a total of up to $18.7M from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. This award will enable GREFFEX to develop and exploit its GreVac(TM) Plug-And-Play Technology to Expedite the Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases to target emerging infectious threats, whether natural or man-made.

GreVac(TM) vaccines are based upon GREFFEX’s proprietary GreGT Genetic Engineering Technology as a fast and flexible plug-and-play vaccine architecture of fully deleted helper virus independent adenoviral vectors of rare serotypes. The proprietary GreGT platform has been built upon two independently modifiable components to provide broad gene transfer applications.

The GreVac(TM) system incorporates versatility and speed to complement and ultimately change the present paradigm of immune protection against infectious diseases with a high eruption potential from the stockpiling of potential vaccine candidates to the just-in-time production of specific vaccines.

With support from the present NIH contract, GREFFEX expects to advance the development of two of its GreVac(TM) influenza vaccines through clinical trials. The activity of a vaccine directed against a highly pathogenic avian influenza will be compared to a novel universal influenza vaccine. This research initiative is funded by the NIAID, NIH, Department of Health and Human Services, under Contract HHS-NIH-NIAID-BAA2018 (BAA-2018 Omnibus Broad Agency Announcement: Research Area 2 (DMID) – Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases).

Share article on social media or email: